Immunotherapy Middle Aged Genetics Guidelines Radiotherapy Glioblastoma PET Radiothérapie Chromatin Carcinoma Overall survival Prostate cancer Genomics Hepatocellular carcinoma Biomarkers Cancer Tumor microenvironment Machine learning Neoplasms Male Autophagy Prognostic factors Cell migration Gene expression Macrophages Transcription Aging Diagnosis P53 Homologous recombination DNA repair Lung cancer Resistance Actin Adult PET/CT Lymphoma Classification Melanoma Mortality Breast cancer Medicine NSCLC Artificial intelligence Dendritic cells Immune checkpoint inhibitors MRI Epigenetics Precision medicine Angiogenesis Therapy Mitochondria Dosimetry Inflammation Humans Metastasis Animals Obesity Metabolism Oxidative stress Epidemiology Female Liver Recurrence Quality of life Migration Head and neck cancer Mouse Bladder cancer Toxicity Ovarian cancer Microfluidics Cytoskeleton Oncology Leukemia Treatment Colorectal cancer Clinical trial Apoptosis COVID-19 Aged Biomarker Survival PARIS team Radiation therapy Tumor Targeted therapy Radiomics France Surgery Cervical cancer Cancer du sein Hypoxia Bevacizumab Human Mutation Ionizing radiation Prognosis Deep learning Chemotherapy